Citius Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Citius Pharmaceuticals stock has a target of 6.00, which predicts an increase of 545.16% from the current stock price of 0.93.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$6.00	$6.00	$6.00	$6.00
Change	+545.16%	+545.16%	+545.16%	+545.16%

* Price targets were last updated on Dec 4, 2025.

Analyst Ratings

The average analyst rating for Citius Pharmaceuticals stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	2	2	2	1	1	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $6	Strong Buy	Maintains	$6	+545.16%	Dec 4, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $6	Strong Buy	Maintains	$6	+545.16%	Aug 13, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $6	Strong Buy	Maintains	$6	+545.16%	Jun 30, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $9 → $6	Strong Buy	Maintains	$9 → $6	+545.16%	Jun 10, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $9	Strong Buy	Maintains	$9	+867.74%	Jun 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

65.10M

Revenue Next Year

161.16M

from 65.10M

147.57%

from 65.10M

EPS This Year

1.94

from -3.38

EPS Next Year

3.16

from 1.94

63.16%

from 1.94

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026	Sep 30, 2027
Revenue	-	-	-	-	-	65.10M	161.16M
Revenue Growth	-	-	-	-	-	-	147.57%
EPS	-5.64	-5.76	-5.57	-5.97	-3.38	1.94	3.16
EPS Growth	-	-	-	-	-	-	63.16%
Forward PE	-	-	-	-	-	0.48	0.29
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	82.2M	180.9M
Avg	65.1M	161.2M
Low	48.4M	140.9M

Revenue Growth

Revenue Growth	2026	2027
High	-	177.8%
Avg	-	147.6%
Low	-	116.4%

EPS Forecast

EPS	2026	2027
High	2.00	3.26
Avg	1.94	3.16
Low	1.86	3.04

EPS Growth

EPS Growth	2026	2027
High	-	68.0%
Avg	-	63.2%
Low	-	56.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.